Defendants: Intravenous Products Co. of America (Inc.) / Product Keywords: ampuls of Endoquin (quinine hydrochloride), Endoferarsan with glycerophosphates (iron arsenic and glycerophosphates), Endoferarsan (iron and arsenic), and emetine hydrochloride / Issue Dates: July, 1929 - FDA Notices of Judgment Collection, 1908-1966 Search Results

Start Over Defendants Intravenous Products Co. of America (Inc.) ✖ Product Keywords ampuls of Endoquin (quinine hydrochloride), Endoferarsan with glycerophosphates (iron arsenic and glycerophosphates), Endoferarsan (iron and arsenic), and emetine hydrochloride ✖ Issue Dates July, 1929 ✖

1. 16092. Adulteration and misbranding of ampuls of Endoquin (quinine hydrochloride), Endoferarsan with glycerophosphates (iron arsenic and glycerophosphates), Endoferarsan (iron and arsenic), and emetine hydrochloride. U. S. v. Intravenous Products Co. of America (Inc.). Plea of guilty. Fine, $200.

Defendants:: Intravenous Products Co. of America (Inc.)
Issue Dates:: July, 1929

Search

Search Constraints

Search Results

Refine by:

Collections

Titles

Defendants

Product Keywords

Issue Dates

Adjudicating Courts